Major efforts were deployed to study the antibody response against SARS-CoV-2.
Antibodies neutralizing SARS-CoV-2 have been extensively studied in the context of …

Middle East respiratory syndrome coronavirus (MERS-CoV) is a betacoronavirus that
causes severe respiratory illness in humans. There are no licensed vaccines against MERS …

Antibodies generated after vaccination or natural pathogen exposure are essential
mediators of protection against many infections. Most studies with viruses have focused on …

Assessment of immune correlates of severe COVID-19 has been hampered by the low
numbers of severe cases in COVID-19 vaccine efficacy (VE) trials. We assess neutralizing …

Hybrid immunity against SARS-CoV-2 has not been well studied in pregnancy. We
conducted a comprehensive analysis of neutralizing antibodies (nAb) and binding …

SARS-CoV-2 infection widely induces antibody response targeting diverse viral proteins,
including typical representative N-terminal domain (NTD), receptor-binding domain (RBD) …

Objectives The specific humoral immune response resulting from inactivated vaccination
following by BA. 5 infection, and predictors of XBB variants re-infection in BA. 5 infection …

The severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) pandemic has caused
more than 676 million cases in the global human population with approximately 7 million …

In this study, we evaluated the immunogenicity and protective immunity of in vitro transcribed
Venezuelan equine encephalitis virus (VEEV TC-83 strain) self-amplifying RNA (saRNA) …

ABSTRACT AdCLD-CoV19-1, a chimeric adenovirus-based severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) vaccine, was previously reported to elicit robust …